Document is current
Any future updates will be listed below
-
Authors
Arjuna, Srividya
Shah, Mauli
Dono, Antonio
Nunez-Rubiano, Luis
Pichardo-Rojas, Pavel S.
Zhu, Jay-Jiguang
Riascos, Roy F.
Luthra, Rajyalakshmi
Roy-Chowdhuri, Sinchita
Duose, Dzifa
Wang, Daniel H.
Lang, Frederick F.
Esquenazi, Yoshua
Ballester, Leomar Y.
-
Funding
Funding for this research was provided by:
National Cancer Institute of the National Institutes of Health (K08CA241651)
Thermo Fisher Scientific (Oncomine Clinical Research grant)
- License Information
-
More Information
Article History
Received: 3 August 2023
Accepted: 20 October 2023
First Online: 30 December 2023
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose. The authors have no competing interests to declare that are relevant to the content of this article. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. The authors have no financial or proprietary interests in any material discussed in this article.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the local ethics regulations and approvals and with the 1964 Helsinki declaration and its later amendments. All procedures were performed in accordance with local institutional review board (IRB MDACC and UTHealth) guidelines.
: Informed consent was obtained from all individual participants included in the study.
